Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Lung cancer screening study aims to reduce unnecessary scares in brazil

NCT ID NCT07279948

Not yet recruiting Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jan 04, 2026 · Last updated May 22, 2026 · Updated 21 times

Summary

This study will observe about 477 current or former smokers in Brazil to see how well lung cancer screening works in a region where other lung diseases are common. The goal is to find out how often screening gives false alarms, which can lead to extra tests and worry. No new treatments are tested; instead, researchers will collect data to improve future screening programs.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    Rio de Janeiro, 20230-130, Brazil

Conditions

Explore the condition pages connected to this study.